The Fenom Pro® point-of-care breath analyzer measures Fractional Exhaled Nitric Oxide (FeNO) molecules. FeNO is an objective biomarker of allergic airway inflammation, an indicator of asthma and other pulmonary conditions. FeNO testing is recommended in the ATS guidelines. Accurate measurement of FeNO levels helps healthcare professionals to correctly prescribe medicines and adjust treatments to reduce exacerbations – providing better overall care to their patients.
FeNO testing has never been easier. For additional information visit fenomasthma.com
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
The Latest News From Vyaire
CHICAGO – January 21, 2020 ― Vyaire Medical, Inc. today announced that its Board of Directors has appointed Gaurav Agarwal as Chief Executive Officer, effective immediately.Read More
CHICAGO, January 15, 2020—Vyaire Medical has announced the U.S. availability of its MX40™ adapter, a reusable telemetry adapter that is compatible with Philips Intellivue MX40 wearable patient monitor.Read More